Mersana Therapeutics to Participate in Investor Conferences in September
Aug 31, 2017 11:00 am UTC| Business
CAMBRIDGE, Mass., Aug. 31, 2017 -- Mersana Therapeutics, Inc. (NASDAQ:MRSN) today announced that Anna Protopapas, President and Chief Executive Officer, will participate in three upcoming investor conferences in...
Aug 31, 2017 11:00 am UTC| Business
OXFORD, United Kingdom, Aug. 31, 2017 -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy (‘DMD’) and C. difficile...
Aug 31, 2017 11:00 am UTC| Business
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Aug. 31, 2017 -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene...
Akcea and Ionis Announce Submission of New Drug Application for Volanesorsen to the U.S. FDA
Aug 31, 2017 11:00 am UTC| Business
CAMBRIDGE, Mass., Aug. 31, 2017 -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) focused on developing and commercializing drugs to treat patients with serious...
Cesca Therapeutics to Participate in the CAR-TCR Summit 2017
Aug 31, 2017 11:00 am UTC| Business
RANCHO CORDOVA, Calif., Aug. 31, 2017 -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that the Company will...
Advanced Accelerator Applications Reports 32% Sales Growth for Second Quarter 2017
Aug 31, 2017 11:00 am UTC| Business
Positive CHMP Opinion for Lutetium Lu 177 Dotatate* (Lutathera®) for GEP-NETS FDA Acknowledged Receipt and Completeness of NDA Resubmission for Lutetium Lu 177 Dotatate* (Lutathera®) and Provided PDUFA Date of January...
Codexis to Present at Four Investment Conferences in September
Aug 31, 2017 11:00 am UTC| Business
REDWOOD CITY, Calif., Aug. 31, 2017 -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at four investment conferences in September: BioCentury 24th Annual...